Salpingectomia e a sua relevância na prevenção do Câncer de Ovário
DOI:
https://doi.org/10.34119/bjhrv7n4-193Keywords:
salpingectomia, Câncer de Ovário, tuba uterinaAbstract
Introdução: Estudos recentes mostraram que muitos casos de câncer de ovário seroso de alto grau (a forma mais agressiva) realmente se originam nas trompas de falópio. Como resultado, a salpingectomia de forma profilática (remoção das trompas de Falópio) está sendo considerada como uma opção de redução de risco para mulheres com alto risco de câncer do ovário, especialmente aquelas com mutações nos genes BRCA1 e BRCA2. Este procedimento pode reduzir potencialmente o risco de desenvolvimento desse tumor sem a necessidade de remoção dos ovários, preservando assim a função hormonal. Objetivo: Investigar, interpretar e revisar os achados sobre salpingectomia profilática e seus impactos quanto à prevenção do câncer de ovário. Metodologia: Utilizou-se a base Medical Literature Analysis and Retrieval System Online (MEDLINE/PubMed), sob os descritos Salpingectomy; Ovarian câncer, com seleção de artigos de revisão e artigos originais, seguindo critérios de elegibilidade. Foram encontrados 413 textos, com seleção inicial de 79, dos quais restaram 42 artigos elegíveis. Resultados: Os artigos, redigidos em língua inglesa, contemplava também publicações de autores e periódicos de diferentes nacionalidades. A maioria dos artigos abrangiam o ano de 2023. Considerações finais: A associação entre salpingectomia e câncer de ovário baseia-se na descoberta de que muitos cânceres de ovário agressivos começam nas tubas uterinas. Como resultado, a salpingectomia está sendo cada vez mais recomendada como estratégia preventiva, especialmente para mulheres com alto risco genético. Esta abordagem visa reduzir a incidência de câncer de ovário, preservando a função ovariana e a saúde geral.
References
GIANNAKEAS, Vasily et al. Salpingectomy and the risk of ovarian cancer in Ontario. JAMA Network Open, v. 6, n. 8, p. e2327198-e2327198, 2023.
KAHN, Ryan M. et al. Salpingectomy for the primary prevention of ovarian cancer: a systematic review. JAMA surgery, 2023.
KAHN, Ryan M.; STONE, Rebecca L.; ROCHE, Kara C. Long. Salpingectomy and Ovarian Cancer Prevention—Reply. JAMA surgery, v. 159, n. 4, p. 470-470, 2024.
TUESLEY, Karen M.; WEBB, Penelope M.; JORDAN, Susan J. Salpingectomy and Ovarian Cancer Prevention. JAMA surgery, v. 159, n. 4, p. 469-470, 2024.
WEBB, Penelope M.; JORDAN, Susan J. Global epidemiology of epithelial ovarian cancer. Nature Reviews Clinical Oncology, v. 21, n. 5, p. 389-400, 2024.
ZADABEDINI MASOULEH, Tahereh et al. Beyond sterilization: a comprehensive review on the safety and efficacy of opportunistic salpingectomy as a preventative strategy for ovarian cancer. Current Oncology, v. 30, n. 12, p. 10152-10165, 2023.
GELDERBLOM, M. E. et al. The effect of opportunistic salpingectomy for primary prevention of ovarian cancer on ovarian reserve: a systematic review and meta-analysis. Maturitas, v. 166, p. 21-34, 2022.
STONE, Rebecca; SAKRAN, Joseph V.; ROCHE, Kara Long. Salpingectomy in ovarian cancer prevention. JAMA, v. 329, n. 23, p. 2015-2016, 2023.
DUUS, Alberte Hjorth et al. Risk of ovarian cancer after salpingectomy and tubal ligation: Prospects on histology and time since the procedure. Gynecologic Oncology, v. 177, p. 125-131, 2023.
KARIA, Pritesh S.; JOSHU, Corinne E.; VISVANATHAN, Kala. Uptake and predictors of opportunistic salpingectomy for ovarian cancer risk reduction in the United States. Cancer Prevention Research, v. 14, n. 12, p. 1101-1110, 2021.
KOTSOPOULOS, Joanne; NAROD, Steven A. Prophylactic salpingectomy for the prevention of ovarian cancer: Who should we target?. International journal of cancer, v. 147, n. 5, p. 1245-1251, 2020.
GADDUCCI, Angiolo et al. Clear cell carcinoma of the ovary: Epidemiology, pathological and biological features, treatment options and clinical outcomes. Gynecologic oncology, v. 162, n. 3, p. 741-750, 2021.
SIDERIS, Michail; MENON, Usha; MANCHANDA, Ranjit. Screening and prevention of ovarian cancer. Medical Journal of Australia, v. 220, n. 5, p. 264-274, 2024.
FALCONER, Henrik et al. Association between pelvic inflammatory disease and subsequent salpingectomy on the risk for ovarian cancer. European journal of cancer, v. 145, p. 38-43, 2021.
NAUMANN, R. Wendel et al. The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage. American Journal of Obstetrics and Gynecology, v. 225, n. 4, p. 397. e1-397. e6, 2021.
KARIA, Pritesh S. et al. Racial and ethnic differences in the adoption of opportunistic salpingectomy for ovarian cancer prevention in the United States. American journal of obstetrics and gynecology, v. 227, n. 2, p. 257. e1-257. e22, 2022.
HANLEY, Gillian E. et al. Outcomes from opportunistic salpingectomy for ovarian cancer prevention. JAMA network open, v. 5, n. 2, p. e2147343-e2147343, 2022.
DARELIUS, Anna et al. Risk of epithelial ovarian cancer Type I and II after hysterectomy, salpingectomy and tubal ligation—A nationwide case‐control study. International Journal of Cancer, v. 149, n. 8, p. 1544-1552, 2021.
AUS, Ali Tariq. Can we prevent ovarian cancer?. Ceska Gynekologie, v. 85, n. 1, p. 49-58, 2020.
CONTE, Carmine et al. Hereditary women’s cancer: management and risk-reducing surgery. Medicina, v. 59, n. 2, p. 300, 2023.
GELDERBLOM, Malou E. et al. First step in implementation of opportunistic salpingectomy for prevention of ovarian cancer: Current care and its determinants. Acta Obstetricia et Gynecologica Scandinavica, v. 102, n. 3, p. 257-269, 2023.
MAGARAKIS, Leonidas et al. Efficacy and safety of sterilisation procedures to reduce the risk of epithelial ovarian cancer: a systematic review comparing salpingectomy with tubal ligation. The European Journal of Contraception & Reproductive Health Care, v. 27, n. 3, p. 230-239, 2022.
CUSIMANO, Maria C. et al. Ovarian cancer incidence and death in average-risk women undergoing bilateral salpingo-oophorectomy at benign hysterectomy. American journal of obstetrics and gynecology, v. 226, n. 2, p. 220. e1-220. e26, 2022.
VAN LIESHOUT, Laura AM et al. Primary prevention of ovarian cancer: a patient decision aid for opportunistic salpingectomy. American Journal of Obstetrics and Gynecology, v. 226, n. 2, p. 234. e1-234. e14, 2022.
YOON, Ju Yoon et al. Genomic catastrophe, the peritoneal cavity and ovarian cancer prevention. The Journal of Pathology, v. 257, n. 3, p. 255-261, 2022.
WONG, Jennifer WH; KILLEEN, Jeffrey L.; CARNEY, Michael E. Completeness of salpingectomy intended for ovarian cancer risk reduction. Gynecologic Oncology, v. 155, n. 2, p. 280-282, 2019.
SOWAMBER, Ramlogan et al. Ovarian cancer: From precursor lesion identification to population-based prevention programs. Current Oncology, v. 30, n. 12, p. 10179-10194, 2023.
BOERNER, Thomas; ROCHE, Kara Long. Salpingectomy for the risk reduction of ovarian cancer: is it time for a Salpingectomy-alone approach?. Journal of minimally invasive gynecology, v. 28, n. 3, p. 403-408, 2021.
RUNNEBAUM, I. B. et al. Ovarian cancer prevention by opportunistic salpingectomy is a new de facto standard in Germany. Journal of Cancer Research and Clinical Oncology, v. 149, n. 10, p. 6953-6966, 2023.
FENG, Zheng et al. Risk-reducing salpingo-oophorectomy among Chinese women at increased risk of breast and ovarian cancer. Journal of Ovarian Research, v. 16, n. 1, p. 125, 2023.
MARCHAND, Greg J. et al. Salpingectomy, tubal ligation and hysteroscopic occlusion for sterilization. Minerva Obstetrics and Gynecology, v. 74, n. 5, p. 452-461, 2022.
GHEZELAYAGH, Talayeh S. et al. Perceptions of risk and reward in BRCA1 and BRCA2 mutation carriers choosing salpingectomy for ovarian cancer prevention. Familial Cancer, v. 19, p. 143-151, 2020.
FILLON, Mike. Opportunistic salpingectomy may reduce ovarian cancer risk. CA: a Cancer Journal for Clinicians, v. 72, n. 2, p. 97-99, 2022.
RUNNEBAUM, Ingo B.; KATHER, Angela. Primary prevention of ovarian cancer by salpingectomy: that's one small step for a surgeon, one giant leap for patients. Journal of Cancer Research and Clinical Oncology, v. 149, n. 10, p. 6799-6801, 2023.
ALHILLI, Mariam M. et al. Comprehensive Care of Women with Genetic Predisposition to breast and ovarian Cancer. In: Mayo Clinic Proceedings. Elsevier, 2023. p. 597-609.
MARTELLI, Gabriele et al. Prophylactic Salpingo-Oophorectomy and Survival After BRCA1/2 Breast Cancer Resection. JAMA surgery, v. 158, n. 12, p. 1275-1284, 2023.
HARNOD, Tomor et al. Hysterectomy and unilateral salpingectomy associate with a higher risk of subsequent ovarian cancer: A population-based cohort study in Taiwan. Medicine, v. 98, n. 48, p. e18058, 2019.
SWANSON, Casey L.; BAKKUM-GAMEZ, Jamie N. Preventing ovarian cancer in high-risk women: one surgery at a time. Clinical Obstetrics and Gynecology, v. 63, n. 1, p. 64-73, 2020.
RIUS, Mariona et al. Opportunistic salpingectomy for ovarian cancer prevention: a call for action. Journal of the American College of Surgeons, v. 237, n. 2, p. 376-378, 2023.
PEREZ, Luiza et al. Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: A systematic review of the literature. Gynecologic oncology, v. 173, p. 106-113, 2023.
MATAN, Liat S. et al. Ovarian cancer risk management in BRCA-mutation carriers: A comparison of six international and national guidelines. European Journal of Obstetrics & Gynecology and Reproductive Biology, v. 278, p. 166-171, 2022.
MATSUO, Koji et al. Opportunistic salpingectomy at the time of laparoscopic cholecystectomy for ovarian cancer prevention: a cost-effectiveness analysis. Annals of Surgery, v. 277, n. 5, p. e1116-e1123, 2023.
MACHADO, Gabrielly Monteiro et al. Fatores de risco associados ao desenvolvimento de Câncer de Ovário: revisão integrativa. Brazilian Journal of Health Review, v. 6, n. 6, p. 32319-32331, 2023.
DE ALBUQUERQUE OLIVEIRA, Luana Rafael et al. Novas perspectivas na terapia do Câncer de Ovário-o uso de inibidores de parp: uma revisão da literatura. Brazilian Journal of Health Review, v. 7, n. 3, p. e70898-e70898, 2024.
